1. Home
  2. WWD vs RPRX Comparison

WWD vs RPRX Comparison

Compare WWD & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Woodward Inc.

WWD

Woodward Inc.

HOLD

Current Price

$332.32

Market Cap

18.8B

Sector

Energy

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$39.43

Market Cap

16.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WWD
RPRX
Founded
1870
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8B
16.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WWD
RPRX
Price
$332.32
$39.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$298.18
$45.75
AVG Volume (30 Days)
530.4K
3.3M
Earning Date
02-02-2026
02-10-2026
Dividend Yield
0.33%
2.37%
EPS Growth
19.63
N/A
EPS
7.19
1.75
Revenue
$3,567,064,000.00
$2,349,844,000.00
Revenue This Year
$12.28
$37.66
Revenue Next Year
$8.54
$2.34
P/E Ratio
$46.73
$22.68
Revenue Growth
7.30
3.70
52 Week Low
$146.82
$29.66
52 Week High
$338.17
$41.70

Technical Indicators

Market Signals
Indicator
WWD
RPRX
Relative Strength Index (RSI) 66.58 49.50
Support Level $321.99 $39.87
Resistance Level $338.17 $40.58
Average True Range (ATR) 7.88 0.78
MACD 0.77 -0.03
Stochastic Oscillator 83.27 34.46

Price Performance

Historical Comparison
WWD
RPRX

About WWD Woodward Inc.

Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: